NYSE American - Delayed Quote USD
Channel Therapeutics Corporation (CHRO)
1.2265
-0.1135
(-8.47%)
At close: June 13 at 3:54:52 PM EDT
1.2200
-0.01
(-0.53%)
After hours: June 13 at 7:56:13 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 3.55M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FRANCIS KNUETTEL II Chief Executive Officer | Purchase at price 0.97 per share. | Indirect | 5,044 | Sep 13, 2024 |
| MALAMUT RICHARD Director | Purchase at price 0.94 per share. | Indirect | 9,825 | Sep 12, 2024 |
| FRANCIS KNUETTEL II Chief Executive Officer | Purchase at price 0.89 - 0.94 per share. | Indirect | 10,955 | Sep 11, 2024 |
| FRANCIS KNUETTEL II Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
| DAVIS TODD CLIFTON Director | Conversion of Exercise of derivative security at price 4.80 per share. | Direct | 140,002 | Feb 21, 2024 |
| FRIEDBERG EZRA M Director | Conversion of Exercise of derivative security at price 4.80 per share. | Indirect | 99,077 | Feb 21, 2024 |
| FRIEDBERG EZRA M Director | Purchase at price 4.78 per share. | Direct | 79,668 | Feb 21, 2024 |
| FRIEDBERG EZRA M Director | Conversion of Exercise of derivative security at price 4.80 per share. | Indirect | 99,077 | Feb 21, 2024 |
Related Tickers
GANX Gain Therapeutics, Inc.
1.7300
-3.89%
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
ASPHF Ascentage Pharma Group International
5.83
0.00%
SILO Silo Pharma, Inc.
0.5874
-3.72%
RADX Radiopharm Theranostics Limited
5.05
-5.25%
ABP Abpro Corporation
0.2150
-11.85%
KMSTF Kadimastem Ltd
5.06
0.00%
ENSCW Leisure Acquisition Corp.
0.0241
+20.50%
TSBX Turnstone Biologics Corp.
0.3345
-6.22%
QNRX Quoin Pharmaceuticals, Ltd.
8.38
-0.12%